➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
McKinsey
Harvard Business School
Baxter
Merck

Last Updated: October 16, 2021

DrugPatentWatch Database Preview

Litigation Details for Finjan, Inc. v. Rapid7, Inc. (D. Del. 2018)


Email this page to a colleague

« Back to Dashboard

Finjan, Inc. v. Rapid7, Inc. (D. Del. 2018)

Docket ⤷  Free Forever Trial Date Filed 2018-10-01
Court District Court, D. Delaware Date Terminated
Cause 35:1 Patent Infringement Assigned To Maryellen Noreika
Jury Demand Plaintiff Referred To
Parties FINJAN, INC.; RAPID7 LLC; RAPID7, INC.
Patents 10,004,237; 10,004,729; 10,005,847; 10,010,508; 10,010,585; 10,016,385; 10,023,892; 10,031,141; 10,071,170; 10,118,901; 10,385,062; 10,385,135; 10,386,359; 10,406,006; 10,449,118; 10,478,478; 10,478,601; 10,493,094; 10,493,303; 10,501,538; 10,585,088; 6,024,657; 6,264,984; 6,359,016; 6,565,449; 6,602,657; 6,610,830; 6,830,253; 6,844,390; 6,858,650; 6,951,844; 6,984,518; 7,008,397; 7,014,610; 7,014,990; 7,128,658; 7,138,546; 7,141,018; 7,141,237; 7,345,014; 7,381,141; 7,449,012; 7,585,493; 7,598,089; 7,611,702; 7,619,004; 7,847,061; 7,858,118; 7,892,547; 7,892,563; 8,007,381; 8,012,480; 8,017,390; 8,062,264; 8,071,546; 8,222,015; 8,222,219; 8,383,610; 8,383,890; 8,404,215; 8,404,702; 8,449,886; 8,460,101; 8,460,381; 8,466,128; 8,501,730; 8,502,026; 8,518,390; 8,518,886; 8,563,008; 8,563,493; 8,602,215; 8,715,118; 8,729,019; 8,729,094; 9,002,657; 9,005,619; 9,006,222; 9,006,223; 9,006,259; 9,012,508; 9,023,397; 9,101,585; 9,302,002; 9,364,493; 9,381,243; 9,402,901; 9,404,118; 9,408,858; 9,408,979; 9,517,023; 9,517,219; 9,598,711; 9,602,858; 9,650,611; 9,657,003; 9,657,012; 9,732,062; 9,890,189; 9,951,016
Attorneys Aaron M. Frankel; David C. Dotson; Hannah Lee; Jarrad M. Gunther; Jennifer H. Forte; John R. Gibson; Jonathan A. Choa; Jordana A. Garellek; L. Norwood Jameson; Lisa Kobialka; Matthew C. Gaudet; Paul J. Andre; Philip A. Rovner; Rachael D. Lamkin; Richard L. Renck; Robin McGrath
Firms Duane Morris, LLP
Link to Docket External link to docket
Biologic Drugs cited in Finjan, Inc. v. Rapid7, Inc.

The biologic drugs covered by the patents cited in this case are ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , and ⤷  Free Forever Trial .

Details for Finjan, Inc. v. Rapid7, Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-05-11 136 Exhibit to a Document Telephone: 650.847.4146 5 12390 El Camino Real, Suite 100 Facsimile: 650.847.4151 …Telephone: 650.847.4146 7 Facsimile: 650.847.4151 8 …background, 2706 08.05.2014 email from Ivan Chaperot regarding security patent landscape … 05/11/20 Page 10 ofPage 5 of 83#: 6092 …from Sally Gillis to Yuval Ben Itzhak regarding patent enforcement project External link to document
2020-05-18 140 Redacted Document DIRECT DIAL: +1 302 657 4906 E-MAIL: RLRenck…involving two of the same asserted patents and two other related patents. Finjan has produced these transcripts…Cisco was an investor in Finjan did not involve patent matters. Ex. B, at 64:2-65:13; 68:12- 16 ( … to. Further, any interest in Finjan’s patent litigation plans that Cisco had as an investor …same interest in obtaining strong and enforceable patents” existed). Likewise, “Plaintiffs have not identified External link to document
2020-05-19 141 Exhibit 1-4 citing United States v. Schwimmer, 892 F.2d 237, 243 (2nd Cir. 1989)). We hold that…rights or interest in enforcement of the patent or management of the litigation.” Tr. 21 (Nov. … with Raptor, namely the validity of the patent, protects the disclosure from waiver. We … the legal g status of the ‘460 patent p …and other legal questions concerning the patent. 3 B. SecurityPoint Employees and External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
McKinsey
Johnson and Johnson
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.